TP10-SRC1LXXLL induced breast cancer cell death in a dose-dependent manner and this effect was not affected by estrogen receptor status given that TP10-SRC1LXXLL severely reduced the viability and proliferation of hormone-unresponsive cells. The gene discussed is ESR1; the disease is breast carcinoma.